|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.19 USD | +0.90% |
|
+4.48% | -10.12% |
| Dec. 09 | Barclays Initiates Viatris at Overweight With $15 Price Target | MT |
| Dec. 08 | Viatris to Sell its Equity Stake in Biocon Biologics for $815 Million | MT |
| Capitalization | 12.89B 11.07B 10.39B 9.68B 17.83B 1,158B 19.37B 120B 46.82B 549B 48.36B 47.34B 2,022B | P/E ratio 2025 * |
-4.29x | P/E ratio 2026 * | 84x |
|---|---|---|---|---|---|
| Enterprise value | 25.72B 22.1B 20.73B 19.32B 35.57B 2,311B 38.66B 240B 93.43B 1,095B 96.51B 94.46B 4,035B | EV / Sales 2025 * |
1.82x | EV / Sales 2026 * | 1.71x |
| Free-Float |
96.32% | Yield 2025 * |
4.3% | Yield 2026 * | 4.57% |
Last Transcript: Viatris Inc.
| 1 day | +0.90% | ||
| 1 week | +4.48% | ||
| Current month | +4.68% | ||
| 1 month | +10.57% | ||
| 3 months | +7.08% | ||
| 6 months | +27.01% | ||
| Current year | -10.12% |
| 1 week | 10.67 | 11.32 | |
| 1 month | 10.15 | 11.32 | |
| Current year | 6.85 | 12.6 | |
| 1 year | 6.85 | 13.13 | |
| 3 years | 6.85 | 13.62 | |
| 5 years | 6.85 | 18.86 | |
| 10 years | 6.85 | 55.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 62 | 2023-03-31 |
Theodora Mistras
DFI | Director of Finance/CFO | 42 | 2023-12-31 |
Abhijit Barve
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wyllie Cornwell
BRD | Director/Board Member | 77 | 2020-11-15 |
James Kilts
BRD | Director/Board Member | 77 | 2020-11-15 |
JoEllen Dillon
BRD | Director/Board Member | 61 | 2020-11-15 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.90% | +4.48% | -12.58% | +3.80% | 12.77B | ||
| -1.54% | -6.11% | +22.23% | +172.09% | 893B | ||
| -0.82% | -2.66% | +33.66% | +13.78% | 486B | ||
| -0.06% | -0.62% | +26.29% | +36.75% | 394B | ||
| -0.76% | +0.64% | +22.59% | +3.51% | 336B | ||
| +0.10% | -1.51% | +27.00% | +19.71% | 280B | ||
| +0.17% | +0.58% | +19.51% | +24.96% | 253B | ||
| -2.06% | -4.10% | -6.65% | -10.93% | 246B | ||
| +0.07% | -2.56% | -61.75% | -35.08% | 207B | ||
| -2.30% | -7.24% | +13.05% | +12.63% | 173B | ||
| Average | -0.76% | -1.76% | +8.34% | +24.12% | 328.11B | |
| Weighted average by Cap. | -1.05% | -2.78% | +16.57% | +54.93% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 14.1B 12.11B 11.36B 10.59B 19.5B 1,267B 21.19B 132B 51.22B 600B 52.9B 51.78B 2,212B | 14.28B 12.27B 11.51B 10.72B 19.75B 1,283B 21.46B 133B 51.87B 608B 53.58B 52.44B 2,240B |
| Net income | -3.21B -2.76B -2.59B -2.41B -4.44B -288B -4.83B -30.01B -11.66B -137B -12.05B -11.79B -504B | 86.37M 74.21M 69.62M 64.87M 119M 7.76B 130M 807M 314M 3.68B 324M 317M 13.55B |
| Net Debt | 12.83B 11.02B 10.34B 9.64B 17.75B 1,153B 19.28B 120B 46.61B 546B 48.14B 47.12B 2,013B | 11.53B 9.91B 9.3B 8.66B 15.95B 1,036B 17.34B 108B 41.9B 491B 43.28B 42.37B 1,810B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-09 | 11.19 $ | +0.90% | 10,149,988 |
| 25-12-08 | 11.09 $ | +1.46% | 9,337,260 |
| 25-12-05 | 10.93 $ | +1.58% | 5,855,860 |
| 25-12-04 | 10.76 $ | -0.74% | 5,229,391 |
| 25-12-03 | 10.84 $ | +1.21% | 5,616,514 |
Delayed Quote Nasdaq, December 09, 2025 at 04:00 pm EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VTRS Stock
Select your edition
All financial news and data tailored to specific country editions
















